Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;48(1):13-25.
doi: 10.30476/IJMS.2021.91645.2289.

Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review

Affiliations
Review

Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review

Arash Amanlou et al. Iran J Med Sci. 2023 Jan.

Abstract

Among the many types of central nervous system (CNS) disorders, seizures and epilepsy severely affect the quality of life and routine daily activity of the sufferers. We aimed to review research studies that investigated the effect of statins on the prevention and treatment of seizures and epilepsy. Both animal models and human studies were included in this review. This article starts with a brief introduction about seizure, its prevalence, treatment, and various animal models of seizures and epilepsy. Next, we discuss statin's mechanism of action, side effects, and effects on neurological disorders with a specific focus on seizures. Finally, the effects of different types of statins on seizures are compared. The present review gives a better understanding of the therapeutic effects of statins on neurological disorders in animal models and human studies. This permits researchers to set up study designs to resolve current ambiguities and contradictions on the beneficial effects of statins on neurological disorders.

Keywords: Epilepsy; HMG-CoA; Hydroxymethylglutaryl-CoA reductase inhibitors; Seizures; Statins.

PubMed Disclaimer

Conflict of interest statement

None declared.

References

    1. Das RR, Herman ST. Statins in epilepsy: prime time? Not yet. Neurology. 2010;75:1490–1. doi: 10.1212/WNL.0b013e3181f962fc. - DOI - PubMed
    1. Singh A, Trevick S. The Epidemiology of Global Epilepsy. Neurol Clin. 2016;34:837–47. doi: 10.1016/j.ncl.2016.06.015. - DOI - PubMed
    1. Fisher RS. The New Classification of Seizures by the International League Against Epilepsy 2017. Curr Neurol Neurosci Rep. 2017;17:48. doi: 10.1007/s11910-017-0758-6. - DOI - PubMed
    1. Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults. Med J Aust. 2018;208:226–33. doi: 10.5694/mja17.00951. - DOI - PubMed
    1. Anurogo D, Ikrar T. Treatment of epilepsy: Background and future directions. Progress and Communication in Sciences. 2014;1:27–41.

Publication types

MeSH terms

Substances